Work

TRAXAR study: a randomized phase 2 trial of axitinib and TRC105 versus axitinib alone in patients with advanced or metastatic renal cell carcinoma (mRCC)

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw373.78

Authors: T. Choueiri, N. Agarwal, T. Ho, S.K. Pal, B. Seon, M. Jivani, B. Adams, R. Shazer, C. Theuer

Institutions: Dana-Farber Cancer Institute, Huntsman Cancer Institute, Mayo Clinic, Mayo Clinic in Arizona, City Of Hope National Medical Center, City of Hope, Roswell Park Comprehensive Cancer Center, Tracon Pharmaceuticals (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2587958542

FWCI: 0.531

Cites:

Cited by: 3

Related to: 10